However, the key result from this study is that, even with appropriate treatment, the prognosis of patients with PPS IB LA HR+/HER2- BC appears to be worse compared to patients with PPS IB (T1c N0, G2–3) ES-TNBC. Here, ERBB2 is linked to breast cancer.